From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.

What recent performance says about Novavax Novavax (NVAX) has been moving on the radar again, with shares showing a mix of ...

Changing guidance around COVID-19 vaccines, specifically, has been central to RFK Jr.'s run as health secretary. A judge just ...

Novavax (NVAX) closed at $9.62 in the latest trading session, marking a -1.23% move from the prior day. The stock exceeded ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Novavax reported a fourth-quarter earnings shift to a profit of 11 cents, compared to a loss of 51 cents a year ago, with revenue hitting $147 million, a 67% increase year-over-year. However, the ...

Novavax swings to profit in Q4 CEO remains optimistic despite U.S. regulatory uncertainties Shares surge over 22% after strong results Feb 26 (Reuters) - Novavax (NVAX.O), opens new tab raised its ...

On a per-share basis, the Gaithersburg, Maryland-based company said it had net income of 11 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by ...